首页 | 本学科首页   官方微博 | 高级检索  
     

神明口服液治疗血管性痴呆的临床与实验研究
引用本文:王长垠,殷春萍,耿惠. 神明口服液治疗血管性痴呆的临床与实验研究[J]. 新中医, 2002, 34(12): 20-22
作者姓名:王长垠  殷春萍  耿惠
作者单位:1. 河北省邯郸市中医院,河北,邯郸,056001
2. 邯郸医学高等专科学校,河北,邯郸,056001
摘    要:目的:观察神明口服液治疗血管性痴呆的疗效及实验研究。方法:对58例患者随机分为神明口服液治疗组32例和脑复康治疗组26例进行治疗观察,并进行相应动物实验研究。结果:总有效率治疗组为75.0%,对照组为46.2%,2组比较,差异有显著性意义(P<0.05)。2组治疗前后的量表(MMSE,HDS,FAQ)积分比较,差异均有显著性意义(P<0.05)。动物实验显示本方可以改善血液流变学指标、增强红细胞膜流动性、提高大鼠脑组织一氧化氮(NO)含量、降低脂褐素(LP)含量。结论:神明口服液实为治疗血管性痴呆的一种安全有效的纯中药制剂。

关 键 词:血管性痴呆 实验研究 神明口服液 药理学 疗效 中药制剂
文章编号:0256-7415(2002)12-0020-03
修稿时间:2002-06-28

Clinical and Experimental Studies on the Treatment of Vascular Dementia by Shenming Oral Liquid
Wang Changyin,Yin chunping,Ceng Hui. Clinical and Experimental Studies on the Treatment of Vascular Dementia by Shenming Oral Liquid[J]. JOURNAL OF NEW CHINESE MEDICINE, 2002, 34(12): 20-22
Authors:Wang Changyin  Yin chunping  Ceng Hui
Abstract:Objective: To observe the effect of Shenming Oral Liquid (SOL) for vascular dementia (VD) clinically and experimentally. Methods: 58 cases of VD were allocated to SOL treatment group (32 cases)and Naofukang treatment group(26 cases)randomly to observe the clinical effect and relevant animal experiments were carried out. Results: The total effective rate was 75. 0% and 46. 2% in treatment group and control group respectively (P<0.05). The scores by MMSE, HDS and FAQ questionaries showed significant difference(P <0.05) before and after treatment in both groups. The animal experiments showed that SOL can improve the index of blood rheology, enhance the fluidity of RBC cell membrane, increase the NO content of brain tissue in rats, and decrease the content of LP. Conclusion: SOL is a safe and pure Chinese drug preparation effective for VD.
Keywords:dementia   vascular  Shenming Oral Liquid  pharmacology   clinic
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号